Vogelxo(R) ABPM Study in Hypogandal Men
Public ClinicalTrials.gov record NCT04558567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Open-Label, Single-Arm Study to Evaluate the Effects of Vogelxo(R) on 24-hour Ambulatory Blood Pressure Monitoring in Hypogonadal Men Using Therapeutic Testosterone Replacement Therapy
Study identification
- NCT ID
- NCT04558567
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Upsher-Smith Laboratories
- Industry
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Interventions
- Vogelxo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 27, 2020
- Primary completion
- Dec 11, 2023
- Completion
- Jan 10, 2024
- Last update posted
- Oct 17, 2024
2020 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Upsher-Smith Clinical Trial Site #6 | Birmingham | Alabama | 35235 | — |
| Upsher-Smith Clinical Trial Site #2 | Anaheim | California | 92801 | — |
| Upsher-Smith Clinical Trial Site #1 | Miami | Florida | 33153 | — |
| Upsher-Smith Clinical Trials Site #7 | Garden City | New York | 11530 | — |
| Upsher-Smith Clinical Trials Site #4 | North Charleston | South Carolina | 29405 | — |
| Upsher-Smith Clinical Trials Site #5 | San Antonio | Texas | 78229 | — |
| Upsher-Smith Clinical Trials Site #8 | San Antonio | Texas | 78744 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04558567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04558567 live on ClinicalTrials.gov.